Vanguard Personalized Indexing Management LLC Purchases 2,518 Shares of CME Group Inc. $CME

Vanguard Personalized Indexing Management LLC grew its position in shares of CME Group Inc. (NASDAQ:CME) by 5.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 48,273 shares of the financial services provider’s stock after purchasing an additional 2,518 shares during the period. Vanguard Personalized Indexing Management LLC’s holdings in CME Group were worth $13,182,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in the company. Empowered Funds LLC increased its holdings in CME Group by 11.5% during the 1st quarter. Empowered Funds LLC now owns 10,027 shares of the financial services provider’s stock valued at $2,660,000 after purchasing an additional 1,037 shares during the period. Marshall Wace LLP grew its holdings in shares of CME Group by 103.1% during the 2nd quarter. Marshall Wace LLP now owns 3,692 shares of the financial services provider’s stock worth $1,018,000 after acquiring an additional 121,707 shares during the period. Federated Hermes Inc. grew its holdings in shares of CME Group by 1,325.2% during the 2nd quarter. Federated Hermes Inc. now owns 23,572 shares of the financial services provider’s stock worth $6,497,000 after acquiring an additional 21,918 shares during the period. Nebula Research & Development LLC purchased a new position in shares of CME Group during the 2nd quarter worth approximately $992,000. Finally, The Manufacturers Life Insurance Company grew its holdings in shares of CME Group by 2.6% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 287,876 shares of the financial services provider’s stock worth $79,344,000 after acquiring an additional 7,397 shares during the period. Institutional investors own 87.75% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have weighed in on CME. Morgan Stanley reduced their target price on CME Group from $362.00 to $353.00 and set an “overweight” rating on the stock in a report on Thursday, April 23rd. Jefferies Financial Group reduced their target price on CME Group from $356.00 to $349.00 and set a “buy” rating on the stock in a report on Thursday, April 9th. TD Cowen reduced their target price on CME Group from $340.00 to $323.00 and set a “buy” rating on the stock in a report on Thursday, April 23rd. Barclays reduced their target price on CME Group from $343.00 to $316.00 and set an “equal weight” rating on the stock in a report on Thursday, April 23rd. Finally, Weiss Ratings downgraded CME Group from a “buy (a-)” rating to a “buy (b+)” rating in a report on Thursday. Ten research analysts have rated the stock with a Buy rating, six have given a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat, CME Group presently has an average rating of “Hold” and an average target price of $305.71.

Insider Activity at CME Group

In related news, insider Hilda Harris Piell sold 5,753 shares of the company’s stock in a transaction that occurred on Monday, May 18th. The stock was sold at an average price of $304.63, for a total value of $1,752,536.39. Following the transaction, the insider directly owned 27,702 shares of the company’s stock, valued at approximately $8,438,860.26. This represents a 17.20% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CEO Terrence A. Duffy sold 35,000 shares of the company’s stock in a transaction that occurred on Friday, May 15th. The shares were sold at an average price of $298.51, for a total value of $10,447,850.00. Following the completion of the transaction, the chief executive officer directly owned 55,630 shares in the company, valued at $16,606,111.30. This trade represents a 38.62% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last three months, insiders have sold 44,044 shares of company stock valued at $13,297,507. 0.30% of the stock is owned by corporate insiders.

CME Group Stock Performance

Shares of CME opened at $269.53 on Monday. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. The business’s 50 day moving average price is $284.79 and its 200-day moving average price is $288.16. CME Group Inc. has a 52 week low of $244.56 and a 52 week high of $329.16. The stock has a market cap of $97.67 billion, a P/E ratio of 23.00, a P/E/G ratio of 3.01 and a beta of 0.21.

CME Group (NASDAQ:CME) last released its quarterly earnings data on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.11 by $0.25. The business had revenue of $1.88 billion for the quarter, compared to analysts’ expectations of $1.77 billion. CME Group had a return on equity of 15.42% and a net margin of 63.19%.The firm’s quarterly revenue was up 14.5% on a year-over-year basis. During the same period in the prior year, the firm posted $2.80 EPS. Equities research analysts anticipate that CME Group Inc. will post 12.28 earnings per share for the current fiscal year.

CME Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, June 25th. Investors of record on Tuesday, June 9th will be given a $1.30 dividend. The ex-dividend date of this dividend is Tuesday, June 9th. This represents a $5.20 annualized dividend and a yield of 1.9%. CME Group’s dividend payout ratio is 44.37%.

CME Group News Roundup

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME announced four new E-mini futures contracts tied to broad-market equity benchmarks, plus new Micro E-mini options on the S&P 500 and Nasdaq-100. These launches could attract more trading volume by giving investors additional, lower-cost ways to hedge and gain market exposure. CME Group to Expand Equity Index Suite with Launch of Four New E-mini Futures Contracts
• Positive Sentiment: The company also said it will expand 24/7 trading for WTI crude oil and gold, which could improve price discovery and make CME’s metals and energy products more attractive to global traders operating outside normal market hours. CME Group to Expand 24/7 Trading for WTI Crude Oil and Gold
• Positive Sentiment: CME launched Nasdaq CME Crypto Index futures and is moving deeper into digital-asset derivatives, giving investors regulated exposure to major cryptocurrencies and potentially opening another growth avenue for the exchange. CME Group Launches Crypto Index Futures Tracking Bitcoin, Solana and XRP
• Neutral Sentiment: Erste Group Bank slightly raised its FY2026 EPS estimate for CME, signaling stable earnings expectations rather than a major change in outlook.
• Negative Sentiment: Some commentary around the CFTC’s crypto oversight has raised concerns about regulatory pressure and market criticism, which could create uncertainty for CME’s expanding crypto-related products. CFTC’s Lone Chair Selig Expands Grip Over Crypto and Prediction Markets

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.